We are live on ! Find out more
MBX

MBX Biosciences
MBX

45 hedge funds and large institutions have $784M invested in MBX Biosciences in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95.24% more ownership

Funds ownership: 0% → 95.24% (+95%)

Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$137M
2
O
OrbiMed
New York
+$87.2M
3
NMC
NEA Management Company
Maryland
+$82.7M
4
DTC
Deep Track Capital
Connecticut
+$69M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$67.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GCM
26
Ghisallo Capital Management
Massachusetts
$779K +$686K +30,000 New
SFM
27
Soros Fund Management
New York
$779K +$686K +30,000 New
TRSOTSOK
28
Teachers Retirement System of the State of Kentucky
Kentucky
$694K +$611K +26,708 New
Jane Street
29
Jane Street
New York
$690K +$608K +26,570 New
Norges Bank
30
Norges Bank
Norway
$650K +$572K +25,000 New
PD
31
Point72 (DIFC)
United Arab Emirates
$624K +$549K +24,011 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$579K +$509K +22,269 New
HF
33
HRT Financial
New York
$562K +$495K +21,637 New
Squarepoint
34
Squarepoint
New York
$428K +$377K +16,470 New
Barclays
35
Barclays
United Kingdom
$426K +$375K +16,400 New
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$405K +$357K +15,600 New
SC
37
Shay Capital
New York
$390K +$343K +15,000 New
DKCM
38
Davidson Kempner Capital Management
New York
$338K +$309K +13,500 New
Marshall Wace
39
Marshall Wace
United Kingdom
$312K +$274K +12,000 New
PAS
40
Point72 Asia (Singapore)
Singapore
$278K +$245K +10,706 New
CM
41
Capula Management
Cayman Islands
$217K +$191K +8,362 New
SIM
42
Sandia Investment Management
Massachusetts
$130K +$114K +5,000 New
Legal & General Group
43
Legal & General Group
United Kingdom
$128K +$114K +5,000 New
ACM
44
Aster Capital Management
United Arab Emirates
$47K +$41.4K +1,810 New
TRCT
45
Tower Research Capital (TRC)
New York
$4K +$3.52K +154 New
1
2

MBX Hedge Fund Activity: Q3 2024 in Review

45 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in MBX Biosciences (MBX) for Q3 2024, worth a combined $784M.

Buyers outnumbered sellers: 45 funds opened new MBX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $137M.

  • 45 institutional investors held MBX Biosciences (MBX) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $784M of MBX Biosciences stock for Q3 2024.
  • 45 funds opened new MBX Biosciences positions in Q3 2024 and 0 closed out, a net change of +45 holders.
  • The largest MBX Biosciences buyer in Q3 2024 was Frazier Life Sciences Management, an estimated $137M added.

Based on aggregated 13F filings for Q3 2024.